ResultsIQ

ResultsIQ › Latest results › Viyash Scientific Limited

Viyash Scientific Limited Q4 FY25 results deck summary

NSE: VIYASH · BSE: 512529

Results deck of 20 May 2025, summarised by AI from the filing.

SeQuent Q4 FY25 revenue ₹4,017 million, up 11.2% YoY, EBITDA ₹569 million, up 38.7%; merger with Viyash on track.

Key takeaways

  1. Q4 FY25 revenue SeQuent Q4 FY25 revenue ₹4,017 million, up 11.2% YoY, with EBITDA ₹569 million, up 38.7%.
  2. Merger timeline Merger completion expected in 12-15 months from September 2024 announcement; process on track.
  3. Combined performance Q4 FY25 combined revenue ₹7,725 million, up 13.2% YoY; combined adj. EBITDA margin 15.8%, up 485 bps.
  4. Growth driver Superior product mix, accelerated launches and improved operational efficiency drove profitability and revenue growth.
  5. Risk Merger completion depends on stock exchange NOC and NCLT filing, with other regulatory approvals to follow.

Original filing on BSE

Viyash Scientific Limited Q1 FY27 results

As filed: Revenue ₹946 cr, EBITDA ₹178 cr, PAT ₹79.3 cr, EBITDA margin 18.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹946 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹920 cr, EBITDA ₹184 cr, PAT ₹66.4 cr, EBITDA margin 20.0%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹920 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.0% in 30 days (Nifty 500: +3.0%).
  • Q3 FY26: Revenue ₹858 cr, EBITDA ₹176 cr, PAT ₹48.5 cr, EBITDA margin 20.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹858 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.7% in 30 days (Nifty 500: +2.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Viyash Scientific Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.